[The implementation of the broth microdilution method to determine bacterial susceptibility to antimicrobial agents]. 2007

Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
Institut für Mikrobiologie, Zentrum für Infektionsmedizin, Stiftung Tierärztliche Hochschule Hannover.

The determination of quantitative data (minimal inhibitory concentrations [MIC values]) using the broth microdilution method is considered the method of choice for in-vitro susceptibility testing of bacterial pathogens. For the inoculation of microtiter plates used in the broth microdilution method, an inoculation density of 5x10(5) CFU/ml has to be achieved according to the CLSI standard. In this study, it was shown that the requested CFU/ml corresponded to an optical density of 0.00027 of a bacterial suspension determined in a spectrophotometer at 625 nm (OD625). The comparison of susceptibility data of clinical isolates determined by agar disk diffusion and, in parallel, by broth microdilution confirmed the comparability of both methods. For most antibiotics the frequency of "very major errors" was below 10%. However, a higher frequency of errors was observed for combinations of antimicrobial agents and bacteria for which no valid breakpoints are available. The comparative testing of cephalothin showed a frequency of"very major errors" of 20.3% for staphylococci and 18.4% for Enterobacteriaceae; for apramycin the frequency of "major errors"was found to be 46.0% for Enterobacteriaceae. The reference strains as recommended in the CLSI Standard M31-S1 should be used for quality assurance.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001424 Bacterial Infections Infections by bacteria, general or unspecified. Bacterial Disease,Bacterial Infection,Infection, Bacterial,Infections, Bacterial,Bacterial Diseases
D015169 Colony Count, Microbial Enumeration by direct count of viable, isolated bacterial, archaeal, or fungal CELLS or SPORES capable of growth on solid CULTURE MEDIA. The method is used routinely by environmental microbiologists for quantifying organisms in AIR; FOOD; and WATER; by clinicians for measuring patients' microbial load; and in antimicrobial drug testing. Agar Dilution Count,Colony-Forming Units Assay, Microbial,Fungal Count,Pour Plate Count,Spore Count,Spread Plate Count,Streak Plate Count,Colony Forming Units Assay, Microbial,Colony Forming Units Assays, Microbial,Agar Dilution Counts,Colony Counts, Microbial,Count, Agar Dilution,Count, Fungal,Count, Microbial Colony,Count, Pour Plate,Count, Spore,Count, Spread Plate,Count, Streak Plate,Counts, Agar Dilution,Counts, Fungal,Counts, Microbial Colony,Counts, Pour Plate,Counts, Spore,Counts, Spread Plate,Counts, Streak Plate,Dilution Count, Agar,Dilution Counts, Agar,Fungal Counts,Microbial Colony Count,Microbial Colony Counts,Pour Plate Counts,Spore Counts,Spread Plate Counts,Streak Plate Counts
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D024881 Drug Resistance, Bacterial The ability of bacteria to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance, Bacterial,Antibacterial Drug Resistance

Related Publications

Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
August 1982, Antimicrobial agents and chemotherapy,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
April 2014, The Veterinary record,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
September 2016, Journal of aquatic animal health,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
March 2016, Journal of aquatic animal health,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
July 1998, Rinsho byori. The Japanese journal of clinical pathology,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
April 2018, Journal of pharmaceutical and biomedical analysis,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
May 2005, Diseases of aquatic organisms,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
November 2015, The Journal of antibiotics,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
January 1977, The Mount Sinai journal of medicine, New York,
Anja Rocksin, and Gerald-Friedrich Gerlach, and Stefan Schwarz
August 2022, Journal of clinical microbiology,
Copied contents to your clipboard!